Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucagon Response to Prandial Insulin Timing in T1D
NCT04079881Phase 2Terminated
- Sponsor
- Washington University School of Medicine
- Start
- Feb 2020
- Primary completion
- Jul 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of human insulin in type 1 diabetes mellitus (T1D), sponsored by Washington University School of Medicine. Started Feb 2020; status: terminated.
02
Drugs
human insulin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT04079881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04079881.